Aginko is a contract research organisation (CRO) providing services for the pharmaceutical, biotechnology and medical device sectors from the proof of concept to regulatory testing.
We work according to the compliance with the FDA regulations, international and industry guidelines, we are able to conduct Good Laboratory Practice (GLP) studies.


The search for novel treatments is osteoarticular disease encompasses identification of relevant targets, design of interventions and assessment of therapeutic efficacy in relations to bone and cartilage disesases.

We have a state-of-the-art pathology laboratory, which provides histological and immunohistological analysis but we can also perform histomorphometric and biomechanical analysis for specific purposes. 


We offer various disease models including a wide range of species such as:

  • Cartilage repair model
  • Arthritis model
  • Fracture model
  • Osteoporosis model
  • Disc model
  • Spine model
  • Infection model


A full histopatological analysis and quantitative report is provided by experienced project managers and pathologists.


We also offer in Vitro R&D for drug screening, toxicology testing and clinical trials services.


We are ready to share our preclinical and clinical studies experience with you and contribute in the development of studies that generate data you need in a timely, efficient and cost-effective manner. We can assist you as required in the crafting of any or all portions of your experimental protocol.



Copyright © 2018 Allrights reserved
AGINKO Research AG
AGINKO Research AG, Route de l'ancienne Papeterie 7
1723 Marly , Switzerland